MEGA-ZYME PANCREATIN TABLETS WITH PROTEOLYTIC ENZYMES
MEGA-ZYME PANCREATIN TABLETS WITH PROTEOLYTIC ENZYMES
Discontinued
DIN Number
02238374
Drug Class
Human
Market Date
Sep 30, 1998
Company
HC
enzymatic therapy (canada) inc.
Product Information
Detailed information about this Health Canada approved drug product, including dosage form, route of administration, and regulatory classification.
Product Details
Health Canada regulatory and product classification information
Regulatory Identifiers
DIN Number02238374
AIG Number0434040001
Classification & Schedule
C
Drug Class
Human
S
Schedule
OTC
A
ATC Code
A09AA02 MULTIENZYMES (LIPASE, PROTEASE ETC)
Product Specifications
Dosage FormTablet
Route of AdministrationOral
AHFS Classification56:16.00
Health Canada Classification
ACTIVE INGREDIENTS (4)
BROMELAINActive
Strength: 25 MG
Monograph: BROMELAIN
CHYMOTRYPSINActive
Strength: 1 MG
Monograph: CHYMOTRYPSIN
PANCREATIN (AMYLASE, PROTEASE, LIPASE)Active
Strength: 1625 MG
Monograph: PANCREATIN (AMYLASE, PROTEASE, LIPASE)
PAPAINActive
Strength: 25 MG
Monograph: PAPAIN